$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
恩杂鲁胺(enzalutamide)治疗效果怎么样呢?
2025-10-19 11:44:20
Check Details
恩杂鲁胺在什么时候服用呢?
2025-10-19 11:44:20
Check Details
恩杂鲁胺能吃多长的时间?
2025-10-19 11:44:20
Check Details
恩杂鲁胺(enzalutamide)是治什么疾病的?
2025-10-19 11:44:20
Check Details
恩杂鲁胺推荐的使用剂量是多少?
2025-10-19 11:44:20
Check Details
恩杂鲁胺国内售价是多少呢?
2025-10-19 11:44:20
Check Details
恩杂鲁胺(MDV 3100)中国进医保了没?
2025-10-19 11:44:20
Check Details
恩杂鲁胺国内在医保目录中吗?
2025-10-19 11:44:20
Check Details
恩杂鲁胺(enzalutamide)在国内的上市日期
2025-10-19 11:44:20
Check Details
恩杂鲁胺在国内怎样购买?
2025-10-19 11:44:20
Check Details
恩杂鲁胺(enzalutamide)有哪些优势呢?
2025-10-19 11:44:20
Check Details
用恩杂鲁胺大概多久会出现耐药情况?
2025-10-19 11:44:20
Check Details
1
2
...
7487
7488
7489
7490
7491
7492
7493
...
10233
10234
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Baxdrostat (Baxfendy) for Hypertension: Aldosterone Synthase Inhibition, Dosing, and Discontinuation Rules
2
Pixclara (Floretyrosine F-18/18F-FET) Glioma PET: Distinguishing Recurrence from Treatment-Related Change
3
Adagrasib (Krazati) for KRAS G12C: NSCLC Dosing, Titration, and CRC Regulatory Update
4
Bexlutry (Lu-177 Dotatate) for SSTR-Positive GEP-NETs: PRRT Dosing and Safety Monitoring
5
Etrasimod for Ulcerative Colitis: 2mg Once Daily, Onset Timeline, and Safety Monitoring
6
Hibsago (Bepirovirsen) Japan Approval: CHB Functional Cure and B-Well Data Essentials
7
FDA Approves Isembyld (apitegromab-mstn), the World’s First Skeletal Muscle-Targeted Therapy for SMA
8
Post-Enzalutamide mCRPC: HRR/PARP, PSMA Radioligand, and Chemotherapy Sequencing
9
Ceritinib for ALK-Positive NSCLC: Indication, Dosing, and Safety Management
10
Acalabrutinib in CLL/SLL Survival Expectation: ELEVATE-TN and ASCEND Long-Term PFS, OS
11
Bosutinib for CML: Time to Response, BCR-ABL Monitoring, and Molecular Remission
12
Bedaquiline for Drug-Resistant TB: 24-Week Regimen, Combination Duration, and When to Stop or Extend